Daniel O'Day
Chairman & CEO, Gilead Sciences | Board Member, Georgetown University & PhRMA
View LinkedIn ProfileExperience39+ Years
LevelLeadership
Executive Overview
Working with Gilead employees around the world to create new possibilities in medicine. Delivering on our long term commitment to groundbreaking science and access so we can help make the world a better, healthier place.
Career Timeline
- Georgetown UniversityCurrentJul 2023–Present· 3 yrs 2 mos
- Board MemberCurrentJul 2023–Present
- PhRMACurrentMar 2019–Present· 7 yrs 6 mos
- Board MemberCurrentMar 2019–Present
- Gilead SciencesCurrentMar 2019–Present· 7 yrs 6 mos
- Chief Executive Officer, ChairmanCurrentMar 2019–Present
- Oct 2019–2024· 4 yrs 3 mos
- Board MemberOct 2019–2024
- 1987–2019· 32 yrs
- Chief Executive Officer, Roche Pharmaceuticals2016–2019
- Chief Operating Officer, Pharma Division2012–2016
- Chief Operating Officer, Diagnostics Division2010–2012
- President and Chief Executive Officer, Molecular Diagnostics (RMD)2006–2010
- General Manager, Denmark, Roche Pharma2003–2006
- Head, Corporate Planning, Nippon Roche KK (Japan)2001–2003
- Lifecycle Leader, Tamiflu1999–2001
- Head Business Unit, Arthritis and Respiratory1998–1999
- Director, Product Marketing, U.S.1996–1998
- Director, Human Resources1995–1996
- Commercial Sales1987–1995
Education
Master's degree
Business Administration and Management, General
Columbia University
Bachelor's degree
Biology, General
Georgetown UniversityExecutive Relationship Map
Reports To
Daniel O'Day
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer